Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks seen down ahead of data slew

(Sharecast News) - London stocks were set for a weaker open on Tuesday following a downbeat session on Wall Street, amid ongoing concerns about protests in China and ahead of a slew of UK data. The FTSE 100 was called to open 18 points lower at 7,492.

CMC Markets analyst Michael Hewson said: "European markets started the week on the back foot yesterday as sporadic unrest across China sparks a selloff in global equities. The weakness spread across to the US, where we saw similar weakness on reports that Apple's iPhone sales could be impacted to the tune of 6m handsets from the current disruption.

"With the rest of the world enjoying life, watching the Football World Cup and learning to live with Covid without masks, Chinese authorities are continuing to double down on a strategy that has zero chance of success, and a population increasingly weary after two years of on-off restrictions, and with no endgame in sight."

On the macroeconomic front, net lending, consumer credit and mortgage approvals data for October are due at 0930 GMT.

In corporate news, budget airline easyJet narrowed full-year losses and said it was ramping up preparations for next summer as travellers looked for value for money during the cost-of-living crisis.

The company posted an annual pre-tax loss of £208m compared with a £1bn loss during the Covid pandemic which shut down air travel.

Elsewhere, AstraZeneca said it had agreed to buy biotechnology company Neogene for up to $320m.

Neogene is a clinical-stage company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts) that offer a novel cell therapy approach for targeting cancer.

"With a shared goal of bringing cell therapies to patients with solid tumours, Neogene's expertise in TCR-T discovery, development and manufacturing will strengthen AstraZeneca's ambition to transform outcomes for patients," it said.

Share this article

Related Sharecast Articles

London midday: FTSE stays up ahead of US inflation
(Sharecast News) - London stocks were off earlier highs but still in the black by midday on Wednesday, helped along by the likes of Experian and Imperial Brands, as investors eyed the latest US inflation reading.
London open: Stocks gain ahead of US inflation; Experian surges
(Sharecast News) - London stocks rose in early trade on Wednesday, helped along by the likes of Experian and Imperial Brands, as investors eyed the latest US inflation reading.
London pre-open: Stocks seen up ahead of US CPI
(Sharecast News) - London stocks were set to rise at the open on Wednesday following a positive session on Wall street, as investors eyed the latest US inflation reading.
London close: Stocks manage gains as unemployment rises
(Sharecast News) - London stocks closed higher on Tuesday, as investors analysed the latest UK jobs data and remarks from Bank of England chief economist Huw Pill.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.